Jeff Yass’s ProShares Ultra CRCL CRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-44,342
Closed -$568K – 14969
2026
Q2
$568K Buy
44,342
+22,858
+106% +$881K ﹤0.01% 9608
2026
Q1
$887K Buy
21,484
+7,384
+52% +$307K ﹤0.01% 8204
2025
Q4
$570K Buy
+14,100
New +$1.21M ﹤0.01% 8473

Other funds holding CRCA

Jeff Yass's CRCA Position: Q3 2026 in Review

Jeff Yass sold out of ProShares Ultra CRCL (CRCA) in Q3 2026, closing a stake of 44,342 shares — an estimated $568K sold.

Jeff Yass first reported a position in CRCA in Q4 2025 and held it in 3 quarters. The position peaked at $887K in Q1 2026. 8 funds tracked by Wall St. Rank hold CRCA as of Q3 2026.

  • Jeff Yass reported no remaining ProShares Ultra CRCL position as of Q3 2026 after selling out during the quarter.
  • Jeff Yass sold 44,342 ProShares Ultra CRCL shares in Q3 2026, an estimated $568K.
  • Jeff Yass first reported a position in ProShares Ultra CRCL in Q4 2025 and held it in 3 quarters.
  • Jeff Yass's ProShares Ultra CRCL position peaked at $887K in Q1 2026.
  • 8 funds tracked by Wall St. Rank held ProShares Ultra CRCL as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.